LCT announced today that 2 patients have become free from insulin injections. This is a fantastic result and without a doubt the overseas investors will be onto the stock. The trials in Russia are being overseen by a big US CRO.
Tonight could be huge on the US listings. The public relations dept of LCT is good at getting the info out to the public.
Still to come is the announcement by the Minister in New Zealand about the NZ trials starting.
Stock up 28% today on good volume.
LCT Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
